I agree. This could easily double by the next report. As well as continued improvements in all operations, I am expecting a big positive revaluation of company assets at the next report. After all, dermatology was written down from about $90M in Dec 2022 to $20M in June 23 on the basis of poor returns, given that this operating unit has already delivered over A$13 in direct contribution over the first 4 months I expect this asset to be revalued significantly.
I agree. This could easily double by the next report. As well as...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.10 |
Change
-0.560(8.41%) |
Mkt cap ! $518.9M | |||
| Open | High | Low | Value | Volume |
| $6.62 | $6.62 | $6.10 | $1.789M | 285.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 721 | $6.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.10 | 768 | 1 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.14 |
Change
-0.560 ( 7.59 %) |
||||
| Open | High | Low | Volume | ||
| $6.55 | $6.58 | $6.13 | 66128 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| MYX (ASX) Chart |